Table 3.

Patient-reported outcomes stratified by gender(N 2846, unless otherwise specified)

	Men (n 1100)(mean ± SD or %)	Women (n 1746)(mean ± SD or %)	p
Patient-reported outcomes (PROs)
BASDAI (0–10) n 2584	5.1 ± 2.0	5.7 ± 1.9	< 0.001
- Fatigue, n 2636	5.7 ± 2.4	6.6 ± 2.2	< 0.001
- Neck, back or hip pain, n 2636	5.6 ± 2.4	6.2 ± 2.2	< 0.001
- Pain other than neck, back or hip, n 2636	4.3 ± 2.7	4.9 ± 2.6	< 0.001
- Discomfort to touch or pressure, n 2636	4.5 ± 2.7	5.6 ± 2.6	< 0.001
- Morning stiffness level, n 2636	5.3 ± 2.6	5.9 ± 2.6	< 0.001
- Morning stiffness duration, n 2584	4.5 ± 2.8	4.7 ± 2.8	0.070
Stiffness (3–12), n 2707	7.7 ± 2.6	7.8 ± 2.4	0.107
Functional limitation (0–54), n 2771	19.1 ± 16.7	21.2 ± 16.0	< 0.001
GHQ-12*, n 2640	4.4 ± 4.2	5.3 ± 4.1	< 0.001
GHQ-12* ≥ 3	564 (55.4)	1060 (65.4)	< 0.001
Diagnosis of anxiety	243 (30.6)	566 (43.3)	< 0.001
Diagnosis of depression	238 (30.1)	472 (36.1)	< 0.001

GHQ-12: 12-item General Health Questionnaire

*A value ≥ 3 implies a risk of psychological distress

Bold values denote statistical significance at the p < 0.05 level